Secondary endpoints included patient-oriented major acute coronary events ( MACE ) ( death , myocardial infarction [ MI ] , and any revascularization ) , device-oriented MACE ( cardiac death , MI , and target lesion revascularization ) , and stent thrombosis at the 9-month clinical follow-up .